关注
H. Yogish Kumar
H. Yogish Kumar
JSSCP, Mysuru
在 jssuni.edu.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Recent advances in novel drug delivery systems and approaches for management of breast cancer: A comprehensive review
U Hani, M Rahamathulla, RA Osmani, HY Kumar, D Urolagin, MY Ansari, ...
Journal of Drug Delivery Science and Technology 56, 101505, 2020
462020
CDK4/6 inhibitors: a brief overview and prospective research directions
T Adon, D Shanmugarajan, HY Kumar
RSC advances 11 (47), 29227-29246, 2021
352021
Colorectal cancer: A comprehensive review based on the novel drug delivery systems approach and its management
U Hani, YK Honnavalli, MY Begum, S Yasmin, RAM Osmani, MY Ansari
Journal of drug delivery science and technology 63, 102532, 2021
272021
Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules
K Ramya, R Suresh, HY Kumar, BRP Kumar, NBS Murthy
Bioorganic & medicinal chemistry 28 (10), 115466, 2020
262020
Semisynthesis of myristic acid derivatives and their biological activities: A critical insight
S Javid, MN Purohit, H Yogish Kumar, K Ramya, NFA Mithuna, ...
Journal of Biologically Active Products from Nature 10 (6), 455-472, 2020
172020
Semisynthetic derivatives of eugenol and their biological properties: A fleeting look at the promising molecules
NF Anjum, MN Purohit, H Yogish Kumar, K Ramya, S Javid, ...
Journal of Biologically Active Products from Nature 10 (5), 379-404, 2020
82020
Discovery of Novel Myristic Acid Derivatives as N-Myristoyltransferase Inhibitors: Design, Synthesis, Analysis, Computational Studies and Antifungal Activity
S Javid, H Ather, U Hani, A Siddiqua, SM Asif Ansari, D Shanmugarajan, ...
Antibiotics 12 (7), 1167, 2023
62023
An efficient herbal approach for treating fungal infection in cervical cancer patients by developing and optimizing a vaginal suppository
M Ghazwani, U Hani, RAM Osmani, M Rahamathulla, MY Begum, ...
International Journal of Polymer Science 2021 (1), 9198387, 2021
62021
An overview of CDK enzyme inhibitors in cancer therapy
P Mounika, B Gurupadayya, HY Kumar, B Namitha
Current Cancer Drug Targets 23 (8), 603-619, 2023
52023
Virtual Screening for Identification of Dual Inhibitors against CDK4/6 and Aromatase Enzyme
SRVMYKH Tenzin Adon,Dhivya Shanmugarajan,Hissana Ather,Shaik Mohammad Asif ...
Molecules 28 (6), 490, 2023
5*2023
Traditional uses, phytochemistry, and ethnopharmacology of Colebrookea oppositifolia Smith: a mini-review
GL Viswanatha, H Shylaja, HY Kumar, MV Venkataranganna, ...
Advances in Traditional Medicine 21, 209-229, 2021
52021
Anticonvulsant Activity Guided Isolation of Acteoside from Methanolic Root Extracts of Colebrookea oppositifolia Smith
GL Viswanatha, HY Kumar, MV Venkataranganna, NBL Prasad, ...
Journal of Biologically Active Products from Nature 9 (5), 328-334, 2019
52019
Enhanced skin permeation of 6-methoxy-2-naphthylacetic acid by salt formation
V Pawar, HY Kumar, R Giridhar, MR Yadav
Drug Delivery 22 (3), 359-366, 2015
32015
Rational design, synthesis, analysis and antifungal activity of novel myristic acid derivatives as N-myristoyltransferase inhibitors
S Javid, D Shanmugarajan, HY Kumar, R Arivuselvam, NF Anjum, ...
Journal of Molecular Structure 1303, 137568, 2024
12024
Molecular and Biochemical Therapeutic Strategies for Duchenne Muscular Dystrophy
L Krishna, A Prashant, YH Kumar, S Paneyala, SJ Patil, SC Ramachandra, ...
Neurology International 16 (4), 731-760, 2024
2024
Design and synthesis of novel N-[3-(benzimidazol-2-ylamino)phenyl]amine and N-[3-(benzoxazol-2-ylamino)phenyl]amine derivatives as potential anticancer agents
HY Kumar, PR Murumkar, BP Srinivasan, V Pawar, MR Yadav
Molecular Diversity, 1-25, 2022
2022
Characteristics of estrous cycle in goats: an update.
H Kumar, MC Yadav
2000
系统目前无法执行此操作,请稍后再试。
文章 1–17